| Literature DB >> 26713336 |
Nut Koonrungsesomboon1,2, Supanimit Teekachunhatean3, Nutthiya Hanprasertpong3, Junjira Laothavorn4, Kesara Na-Bangchang4, Juntra Karbwang5.
Abstract
PURPOSE: This study aimed to evaluate the applicability of the principles and informed consent form (ICF) template proposed by the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) in a clinical pharmacokinetic study by comparing the volunteers' understanding of the enhanced ICF (developed based on the SIDCER methodology) and the conventional ICF (which was previously approved by local Ethics Committee and used in the clinical study).Entities:
Keywords: Clinical research; Clinical study; Healthy subjects; Healthy volunteers; Informed consent; Understanding
Mesh:
Year: 2015 PMID: 26713336 PMCID: PMC4792335 DOI: 10.1007/s00228-015-2000-2
Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN: 0031-6970 Impact factor: 2.953
The enhanced ICF and the conventional ICF
| Enhanced ICF | Conventional ICF | |
|---|---|---|
| Number of pages | 4 | 7 |
| Number of required elements provided | 21 | 15 |
| General items | ||
| Recognition that this is research | ✓ | ✓ |
| Subject’s responsibility | ✓ | ✓ |
| Confidentiality of records | ✓ | ✓ |
| Who can access the data | ✓ | Not stated |
| Research contact person(s) | ✓ | ✓ |
| Rights of the subject | ||
| Right to refuse | ✓ | ✓ |
| Right to withdraw | ✓ | ✓ |
| Consequences of withdrawal | ✓ | Not stated |
| Right to receive new relevant information | ✓ | Not stated |
| Scientific aspects | ||
| Subject eligibility | ✓ | ✓ |
| Number of subjects required | ✓ | ✓ |
| Purpose of the study | ✓ | ✓ |
| Trial treatment | ✓ | ✓ |
| Trial procedures | ✓ | ✓ |
| Duration of the subject’s participation | ✓ | Not stated |
| Ethical aspects | ||
| Foreseeable risks | ✓ | ✓ |
| Expected direct and/or indirect benefits | ✓ | Not cleara |
| Participant termination criteria | ✓ | Not stated |
| Prorated payment for participation | ✓ | ✓ |
| Anticipated expenses | ✓ | ✓ |
| Compensation for injury | ✓ | ✓ |
a“No direct benefit from study participation” was not stated
Fig. 1Study procedure
Demographic data of the participants (n = 550)
| Enhanced ICF ( | Conventional ICF ( | |
|---|---|---|
| Gender | ||
| Male | 102 | 107 |
| Female | 173 | 168 |
| Generation | ||
| Generation Y | 173 | 195 |
| Generation X | 72 | 58 |
| Baby boomers | 30 | 22 |
| Educational level | ||
| Level 1 | 44 | 43 |
| Level 2 | 208 | 210 |
| Level 3 | 23 | 22 |
Data represent the number of participants. Generation was divided into three subgroups: (1) generation Y includes participants who were born between 1982 and 2000; (2) generation X includes participants who were born between 1965 and 1981; and (3) baby boomers includes participants who were born between 1946 and 1964. Educational level was divided into three sub-levels: level 1 represents high school level or lower; level 2 represents bachelor degree or equivalent, diploma degree, or undergraduate level; and level 3 represents master/doctoral degree or equivalent, or graduate level.
Fig. 2The distribution of the post-test score of the participants. Black bars represent the enhanced ICF group; gray bars represent the conventional ICF group
Fig. 3Proportions of the participants whose post-test score was satisfied according to the 80 % passing level (the primary endpoint). # Relative risk is the ratio derived from the proportion of the participants in the enhanced ICF group whose post-test scores were satisfied according to the 80 % passing level divided by that of the conventional ICF group. * Chi-square test
Fig. 4Proportions of the participants who correctly answered each item in the post-test questionnaire. # Relative risk is the ratio derived from the proportion of the participants in the enhanced ICF group who correctly answered each item in the post-test questionnaire divided by that of the conventional ICF group. * Chi-square test